4-electrode tablet ECG vs standard 12-lead ECG: see which is faster and clearer
Official title: 4-electrode ECG (DigitalCardio®) vs Standard 10-electrode ECG: Evaluating Ease of Use and Recording Quality
Run by Clinique Bizet · NCT07732283 · Data updated 2026-11-12
This study tests whether the 4-electrode DigitalCardio tablet ECG can record a full ECG faster and with comparable trace quality to a standard 12-lead ECG in adults with heart conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Clinique Bizet Academic / other |
| Locations | 2 sites (Paris and 1 other locations) |
| Status | Recruiting |
| Started | September 4, 2026 |
| Main results expected | December 2026 |
| Study ends | March 2027 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07732283 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with current or prior cardiac conditions, inpatients or outpatients, able to consent, and without implantable cardiac devices that affect ECG readings.
✕Probably not a fit
Patients with conditions or devices that uniquely affect ECG interpretation or those who cannot tolerate electrode placement may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized crossover trial compares a 4-electrode tablet-based ECG system (DigitalCardio/CardioSecur) with a standard 12-lead ECG in hospitalized and outpatient cardiology patients. Participants receive both ECG tests in random order, performed by the same operator, to assess recording time, trace quality (QRS duration, QT interval, frontal axis, and lead integrity), and clinician satisfaction. The study focuses on efficiency and diagnostic accuracy to determine if the tablet system can streamline workflow without compromising data quality. Eligible adults with cardiac conditions or follow-up for suspected disease are included, while those with implantable devices or contraindications to electrode placement are excluded. The sponsor is Clinique Bizet, with sites in Paris, France.
Why it matters
Potential benefit: If successful, clinicians could record ECGs more quickly with similar quality, potentially improving clinic flow and patient experience.
How similar studies have gone: Previous work has explored simplified ECG setups; this study directly compares efficiency and quality in a crossover design to establish comparative performance.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Hospitalized Cardiology Patients: * Age minimum 18 years * Hospitalized for an acute or chronic cardiac condition (e.g., heart failure, acute coronary syndrome, arrhythmia, valvular heart disease, etc.) * Ability to give informed consent * Hemodynamic stability permitting the performance of an ECG without clinical risk Cardiology Outpatients: * Age minimum of 18 years * Follow-up for a known cardiac condition or suspected cardiovascular disease * No contraindications to performing an ECG * Informed consent obtained Exclusion Criteria: * Minor patient (\< 18 years of age) * Adult subject under legal protection, under temporary guardianship, curatorship, or tutelage * Patient refusing to participate in the study * Presence of an implantable cardiac device (e.g., pacemaker, defibrillator) that may interfere with ECG measurements * Severe skin condition preventing the placement of electrodes * Physical or cognitive inability to follow the study protocol * Current pregnancy
Where it's running
-
Bizet Clinic
Paris, France Recruiting -
Benkessou
Paris, France Not yet recruiting
Study contacts
- Study coordinator: Bouchra BENKESSOU Chef de projet Recherche Clinique
- Email: b.benkessou@hexagone-sante-paris.fr
- Phone: +33 7 64 48 60 16
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pediatric Cardiac Oxygenation Monitoring During Open-Heart Surgery
This study tests whether the SpectroCor Tissue Oxygenation Monitor and its Sensor can track heart tissue oxygen levels in children undergoing open-heart surgery.
-
Magnetocardiography in people with chest pain and non-obstructive heart arteries
This study uses magnetocardiography to see if it can help identify non-obstructive myocardial ischemia in adults with acute chest pain.
-
AI-assisted cardiac CT to predict coronary artery disease risk
This project will try using AI-enhanced heart CT scans to better predict future coronary events in adults who are already getting a clinical cardiac CT.
-
COMA.NET: Targeted treatment for coronary microcirculation problems
This trial will test whether tailoring medicines based on intracoronary microvascular testing improves quality of life for people with ischemia but no large artery blockages.
-
Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease
This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.